• News

    NIH Director’s Blog: Tackling the Bottlenecks in the Drug Development Pipeline

    Date: February 27, 2013

    In his latest blog, NIH Director Francis Collins presents a few startling figures on the slow pace of drug discovery:  the average length of time from target discovery to FDA approval of a new drug is 14 years, the failure rate exceeds 95 percent, and the cost per successful drug is more than $2 billion. Science could work to help science, however, as discoveries like biochips to determine drug-safety might someday reduce the number of necessary clinical trials and expedite the process. Find out more about efforts to ease the bottleneck on Collins’ blog.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details